Aradhana Sarin

Executive Director and Chief Financial Officer, AstraZeneca

About

Aradhana Sarin is the Executive Director and Chief Financial Officer of AstraZeneca, the biopharmaceutical company. She has been a member of the AstraZeneca Board and its finance chief since August 2021. She joined after AstraZeneca's acquisition of Alexion Pharmaceuticals, where she had been Chief Financial Officer. She reports to the chief executive, Pascal Soriot.

Sarin trained as a medical doctor in India and practised for two years in India and Africa. Her degrees are an M.B.B.S. from the University of Delhi and an MBA from Stanford Business School. She then worked in healthcare investment banking at JP Morgan, UBS and Citi. She joined Alexion in November 2017 as Chief Business and Strategy Officer and later became its Chief Financial Officer. Another pharmaceutical leader with a page on Whoo is Vas Narasimhan of Novartis.

Whoo compiled this page from public sources: AstraZeneca leadership page, AstraZeneca press release, June 2021, CFO Dive. It is not affiliated with or endorsed by Aradhana Sarin. Are you Aradhana Sarin? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Executive Director and Chief Financial Officer — AstraZeneca


August 2021 – Present

  • Member of the Board and finance chief of AstraZeneca

  • Joined after AstraZeneca's acquisition of Alexion
  • Chief Financial Officer — Alexion Pharmaceuticals

  • Joined Alexion in November 2017 as Chief Business and Strategy Officer
  • Investment banking — Citi, UBS and JP Morgan

  • Managing Director, Healthcare Investment Banking at UBS and Healthcare Corporate & Investment Banking at Citi

  • M&A advisory and healthcare roles at JP Morgan

Education

MBA — Stanford Business School

M.B.B.S. — University of Delhi

Projects